E-MAIL   PASSWORD Forgot password?New user?
Obesity

Managing Cardiometabolic Risk: The Role of Pharmacotherapy in the Treatment of Overweight and Obesity

Archived CME Activity

 
The epidemic of overweight and obesity in the US has resulted in a marked increase in the prevalence of diabetes and the metabolic syndrome. Although we have made great strides in addressing traditional cardiovascular (CV) risk factors, patients with cardiometabolic risk—particularly those with excess central adiposity—still experience a high rate of major CV events. This considerable “residual” risk has left researchers and clinicians searching for new therapeutic approaches through which more favorable patient outcomes might be achieved.

    The Metabolic Syndrome: Insights and Applications

    CME Medical Crossfire Cardiovascular, Oct 2007

    Managing Cardiometabolic Risk: The Role of Pharmacotherapy in the Treatment of Overweight and Obesity

    CME Medical Crossfire Cardiovascular, Oct 2007

     
    Page 1 

    Women's Health / Gynecology

    Also In Global Health News: Congo Security Warnings; Niger Food Crisis; Drug Cost In Developing Countries; Measles Vaccination In China
    Fri, 03 Sep 2010 06:00:00 PDT

    Cancer / Oncology

    Celsion Receives SBIR Grant To Expand Its Technology Platform
    Fri, 03 Sep 2010 05:00:00 PDT
    View more >>

    • The Metabolic Syndrome: Insights and Applications

      This educational activity is designed for cardiologists and other health care professionals interested in or involved with the management of patients cardiometabolic risk.